Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70)

Erstveröffentlichung
2015
Authors
Hanusch, Claus
Schneeweiss, Andreas
Loibl, Sibylle
Untch, Michael
Paepke, Stefan
et al.
Wissenschaftlicher Artikel


Published in
Clinical Cancer Research ; 21 (2015), 13. - S. 2924-2931. - ISSN 1078-0432. - eISSN 1557-3265
Link to publication
https://dx.doi.org/10.1158/1078-0432.CCR-14-2774
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: PATHOLOGICAL COMPLETE RESPONSE | OPEN-LABEL | ADJUVANT CHEMOTHERAPY | PLUS TRASTUZUMAB | PHASE-2 TRIAL | BIBW 2992 | LAPATINIB | THERAPY | PERTUZUMAB | SURVIVAL
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record